ZLCS Share Price |
||||
| Open | 1.15 | Change | Price | % |
| High | 1.29 | 1 Day | 0.03 | 2.61 |
| Low | 1.12 | 1 Week | 0.00 | 0.00 |
| Close | 1.18 | 1 Month | 0.00 | 0.00 |
| Volume | 1155992 | 1 Year | 0.00 | 0.00 |
| 52 Week High 6.67 | ||||
| 52 Week Low 3.61 | ||||
| ZLCS Important Levels | |
| Resistance 2 | 1.34 |
| Resistance 1 | 1.27 |
| Pivot | 1.20 |
| Support 1 | 1.09 |
| Support 2 | 1.02 |
| NASDAQ USA Most Active Stocks | |||
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| DCTH | 0.16 | -33.33% | |
| FTR | 1.22 | 8.93% | |
| FTR | 1.22 | 8.93% | |
| ASTI | 0.00 | 0.00% | |
| FNFG | 10.18 | -0.20% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| NASDAQ USA Top Gainers Stocks | |||
| OPXAW | 0.12 | 200.00% | |
| AVEO | 1.25 | 71.23% | |
| LOCM | 0.09 | 50.00% | |
| MYRX | 0.09 | 50.00% | |
| SNCR | 16.24 | 33.33% | |
| QUIK | 1.60 | 31.15% | |
| WRES | 0.09 | 28.57% | |
| IIN | 8.35 | 27.48% | |
| IIN | 8.35 | 27.48% | |
| IIN | 8.35 | 27.48% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| HCIIP | 10.10 | -67.52% | |
| TOPS | 0.80 | -66.67% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| SPIR | 0.01 | -50.00% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
Zalicus Inc. (NASDAQ: ZLCS)
| ZLCS Technical Analysis | 2 |
| As on 15th Jul 2014 ZLCS Share Price closed @ 1.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.57 & Buy for SHORT-TERM with Stoploss of 1.11 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| ZLCS Target for June | |
| 1st Target up-side | N/A |
| 2nd Target up-side | N/A |
| 3rd Target up-side | N/A |
| 1st Target down-side | N/A |
| 2nd Target down-side | N/A |
| 3rd Target down-side | N/A |
Zalicus Inc. ( NASDAQ USA Symbol : ZLCS ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
52.54 0.81 (1.57 %) LT : Buy ST : Strong Buy |
ABIO
2.35 -0.10 (-4.08 %) LT : Sell ST : Sell |
ABMD
144.49 -0.24 (-0.17 %) LT : Strong Buy ST : Strong Buy |
ACAD
29.24 0.56 (1.95 %) LT : Sell ST : Sell |
ACHC
48.03 0.47 (0.99 %) LT : Buy ST : Strong Buy |
|
|
|
||||||||||||||||||||||
Interactive Technical Analysis Chart Zalicus Inc. ( ZLCS NASDAQ USA )
Your Comments and Response on Zalicus Inc.
ZLCS Business Profile
Zalicus Inc. (Zalicus) is a biopharmaceutical company that discovers and developsl treatments for patients suffering from pain and immuno-inflammatory diseases. The Company has a portfolio of clinical-stage product candidates targeting pain and immuno-inflammatory diseases and have entered into multiple revenue-generating collaborations with large pharmaceutical companies relating to other products, product candidates and drug discovery technologies. It focuses on the discovery and development of selective ion channel modulators and its combination high throughput screening technology (cHTSTM) to discover new product candidates for its portfolio or for its collaborators in the areas of pain, inflammation, oncology and infectious disease.